OVARIAN CANCER and US: statin cancer risk

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label statin cancer risk. Show all posts
Showing posts with label statin cancer risk. Show all posts

Thursday, January 19, 2012

PLoS ONE: Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy



Blogger's Note: Table S1 does not specifically show gyn/ovarian cancers unless they have been reported in 'other' or 'unspecified'; a search of the document for 'gyn'/'ovarian'/'ovary' did not provide a result

Background

Statin therapy reduces the risk of occlusive vascular events, but uncertainty remains about potential effects on cancer. We sought to provide a detailed assessment of any effects on cancer of lowering LDL cholesterol (LDL-C) with a statin using individual patient records from 175,000 patients in 27 large-scale statin trials.


Table S1.
Number of patients with a report of cancer (number of cancer deaths), by site and trial.
(PDF)

Conclusion

"........ The present report now demonstrates clearly that such reductions in LDL cholesterol do not increase the rate of cancer or cancer death, overall or at any particular site, during a treatment period of about 5 years (and more prolonged follow-up in some of the trials does not indicate any later excess) even among older individuals or those who have their cholesterol levels reduced to very low levels. These findings provide considerable reassurance about the safety of using more intensive statin regimens to lower LDL cholesterol levels substantially in patients who remain at high risk of major vascular events."